Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

REVISED PX TALK: Somacis EUR1.03bn 7NC1 Sr Sec FRNs

HYC European Market: Deal Flow - General

Ticker

Security

Term

Tranche Size

IPT

Price Talk

Revised Price Talk

SOMACI

Senior Secured Floating Rate Notes

7NC1

EUR1.03bn

E+400 area / par

E+375-400 / par

E+350-375 / par



  • Price Progression:
    • Revised price talk: E+350-375 / par
    • Price talk: E+375-400 / par
    • IPT: E+400 area / par
  • Issuer: Castello (BC) Bidco S.p.A (Somacis)
  • Ticker: SOMACI
  • Size: EUR1.03bn
  • Format: 144A/Reg S
  • Security: Senior Secured Floating Rate Notes (7y)
  • Issue Ratings: B2 / B (positive/stable)
  • Optional Redemption: NC1 (Par) (MWC B+50bp)
  • Change of Control: CoC at 101
  • Listing: Luxembourg Stock Exchange
  • Law: New York
  • Denominations: 100kx1k
  • Physical Bookrunners: Morgan Stanley (B&D), Bank of America, Credit Agricole CIB
  • Joint Bookrunners: ING, Mediobanca, Nomura, UBS Investment Bank
  • UOP: redeem the Issuer's existing EUR760m sr sec FRN due 14-Nov-2031 (callable at 100), fund a EUR260m distribution to the shareholders of the Issuer, and pay transactions fees and expenses
  • Equity sponsor: Bain (64.2%), Chequers (14.4%), and other minority co-investors
  • Biz: A leading global manufacturer of high-tech, high-reliability, mission-critical printed circuit boards in the aerospace & defence, medtech and AI supply chain sectors
  • HQ: Castelfidardo, Ancona, Italy

Marketing:


  • Investor Call: 11:00am UKT 16th November
  • Fixed income investor meetings: 16th & 17th November
  • Books close: 1:00pm UKT 18th November (from 12:00pm)

Global Investor Call Registration Link: https://www.netroadshow.com/events/login/1PeTHmohTJwgJa77EiL9r9LZbVmGisXsfJDdM
NRS & OM Access: www.netroadshow.com/nrs/home/#!/?show=fb27c930

We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.